Proinflammatory cytokines, transforming growth factor-β1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates

Chest

Volumn 128, Issue 2, 2005, Pages 690-697

  Chung, Chi Li ^b   Chen, Chi Hung ^a   Sheu, Joen Rong ^b   Chen, Yi Chu ^c   Chang, Shi Chuan ^c,d  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Fibrinolysis; Loculation; Malignancy; Pleural effusion; Proinflammatory cytokines; Tuberculosis

Indexed keywords

CYTOKINE; LACTATE DEHYDROGENASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULOSIS;

EID: 23744505469     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.2.690     Document Type: Article

References (31)

1. Light RW. Pleural diseases. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; 151-181
2. Himelman RB, Callen PW. The prognostic value of loculations in parapneumonic pleural effusions. Chest 1986; 90:852-856
3. Huang HC, Chang HY, Chen CW, et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion or empyema. Chest 1999; 115:751-756
4. McLoud TC, Flower CDR. Imaging the pleura: sonography CT, MR imaging. AJR Am J Roentgenol 1991; 156:1145-1153
5. Yang PC, Luh KT, Chang DB, et al. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol 1992; 159:29-33
6. Davies CWH, Traill ZC, Gleeson FV, et al. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999; 115:729-733
7. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on the fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003; 123:1185-1195
8. Tillet WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. J Thorac Surg 1951; 21:275-297
9. Davies RJO, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52:416-421
10. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med 1999; 159:37-42
11. Idell S, Girard W, Koenig KB, et al. Abnormalities of pathways of Fibrin turnover in the human pleural space. Am Rev Respir Dis 1991; 144:187-194
12. Bithell TC. Blood coagulation, In: Lee GR, Bithell TC, Foerster J, et al, eds. Wintrobe's clinical hematology. 9th ed, Philadelphia, PA: Lea & Febiger, 1993; 566-615
13. Idell S, Zwieb C, Kumar A, et al. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992; 7:414-426
14. Agrenius V, Chmielewska J, Widström O, et al. Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion. Am Rev Respir Dis 1989; 140:1381-1385
15. Hua CC, Chang LC, Chen YC, et al. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 1999; 116:1292-1296
16. Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995; 161:315-317
17. Philip-Joët F, Alessi MC, Philip-Joët C, et al. Fibrinolytic and inflammatory processes in pleural effusions. Eur Respir J 1995; 8:1352-1356
18. Dvorak HF. Tumors: wounds that do not heal; similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-1659
19. Idell S, Mazar AP, Bitterman P, et al. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 2001; 163:578-584
20. Sporn MB, Roberts AB, Wakefield LM, et al. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987; 105:1039-1045
21. Chen DS, Lee YCG, Rogers JT, et al. Vascular endothelial growth factor level correlates with transforming growth factor-β isoform levels in plerual effusions. Chest 2000; 118:1747-1753
22. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292
23. Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507-513
24. Lomas DJ, Padley SG, Flower CDR. The sonographic appearances of pleural fluid. Br J Radiol 1993; 66:619-624
25. de Pablo A, Villena V, Echave-Sustaeta J, et al. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997; 112:1293-1297
26. Good JT, Taryle DA, Hyers TM, et al. Clotting and fibrinolytic activity of pleural fluid in a model of pleural adhesions. Am Rev Respir Dis 1978; 118:903-908
27. Gürsel G, Gökcora N, Elbeg S, et al. Tumor necrosis factor-alpha (TNF-α) in pleural fluids. Tuber Lung Dis 1995; 76:370-371
28. Söderblom T, Nyberg P, Teppo AM, et al. Pleural fluid interferon-γ and tumor necrosis factor-α in tuberculous and rheumatoid pleurisy. Eur Respir J 1996; 9:1652-1655
29. Orphanidou D, Gaga M, Rasidakis A, et al. Tumor necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion. Respir Med 1996; 90:95-98
30. Lee YCG, Lane KB. The many faces of transforming growth factor-β in pleural diseases. Curr Opin Pulm Med 2001; 7:173-179
31. Offner FA, Feichtinger H, Stadlmann S, et al. Transforming growth factor-β synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol 1996; 148:1679-1688